Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Da-Wei Jin
Observed name:
Dawei Jin
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
BGI Group (China),
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital,
BGI Genomics
ORCID:
0009-0007-1643-2085
Observed ORCID:
0009-0007-1643-2085
OpenAlex ID:
A5102692425
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
2024
·
Jing Wu
, Shilong Zhang
, et al.
·
Nature Communications
·
19
PDF
Utilization of tumor-informed circulating tumor DNA in detecting minimal residual disease and guiding adjuvant therapy in liver cancer.
2024
·
De-Zhen Guo
, Shi-Yu Zhang
, et al.
·
Journal of Clinical Oncology
·
5
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response
2025
·
Shi-Yu Zhang
, De-Zhen Guo
, et al.
·
Cancer Letters
·
3
[Application of Next Generation Sequencing to Screen the Neonatal Thalassemia Genes].
2015
·
Mei Tan
, Sen Lu
, et al.
·
PubMed
·
3
Show more works
View as search
Works count:
4
Citation count:
30
H-index:
3
I10-index:
1
Year
Topic
Type